EUVIMEDDescubrir EUVIMED
Open access · CC BY-NC-ND 4.0

Development of a requirement for exogenous insulin treatment in dogs with hyperglycemia

Angielee DiNinni, Rebecka S Hess iD

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.16990 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Angielee DiNinni and 1 co-authors. Institution: Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Hyperglycemia, Diabetes Mellitus, Type 2, Dog Diseases. Cited 1 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Background

It has been suggested that overt diabetes mellitus in dogs be defined based on a persistent fasting blood glucose concentration (BGC) >144 mg/dL.

Objective

Determine the number of dogs with randomly identified hyperglycemia without insulin-treated diabetes mellitus (ITDM) that later develop a need for exogenous insulin treatment. Animals A total of 1318 dogs examined at a university teaching hospital without ITDM and with randomly identified hyperglycemia.

Methods

Retrospective longitudinal study. Hyperglycemia was defined as randomly identified BGC above >112 mg/dL, moderate hyperglycemia as BGC >144 mg/dL but <200 mg/dL and pronounced hyperglycemia as BGC ≥200 mg/dL. Dogs were defined as having ITDM if they were treated with insulin. Follow-up was attempted 7 to 12 years after hyperglycemia was documented to determine if over time dogs developed a need for exogenous insulin treatment.

Results

Twenty-nine of 824 dogs (3.5%) with hyperglycemia and follow-up information developed ITDM, including 3/824 dogs (0.4%) with moderate hyperglycemia, and 2/824 dogs (0.2%) with pronounced hyperglycemia. Most dogs with hyperglycemia that developed ITDM (24/29, 83%) had BGC ≤144 mg/dL. Among dogs that eventually developed a need for exogenous insulin treatment, no association was found between the degree of hyperglycemia and the time interval between documentation of hyperglycemia and diagnosis of ITDM. Logistic regression determined that BGC is not significantly associated with ITDM. Conclusions and Clinical Importance Most dogs with randomly identified hyperglycemia did not develop a need for exogenous insulin treatment. Other criteria could be required to augment the definition of overt DM in non-insulin treated dogs.

Subjects

MeSH terms (MEDLINE)

HyperglycemiaDiabetes Mellitus, Type 2Dog DiseasesHumansDogsAnimalsRetrospective StudiesLongitudinal StudiesInsulinBlood Glucose

Author keywords

caninediabetes mellitusdiabeticglucocorticoidshyperadrenocorticismsteroids

Substances

InsulinBlood Glucose

Authors and institutions

  • Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID profiles: Rebecka S Hess

Cite

APA

DiNinni, A., & Hess, R. S. (2024). Development of a requirement for exogenous insulin treatment in dogs with hyperglycemia. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16990

Vancouver

DiNinni A, Hess RS. Development of a requirement for exogenous insulin treatment in dogs with hyperglycemia. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.16990

BibTeX
@article{DiNinni2024,
  author = {DiNinni, Angielee and Hess, Rebecka S},
  title = {Development of a requirement for exogenous insulin treatment in dogs with hyperglycemia},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.16990}
}
Start for free →